Company · CIK 0001133416 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
GALECTIN THERAPEUTICS INC · GALT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 MForm 4 → | Aug 4, 7:52 am EDT | Richard E UihleinDirector, 10% Owner | 34,376,167 | $3.08 | $105,806,980 | 44,713,843 | — | |
| Jul 14, 2026 SForm 4 → | Jul 16, 5:39 pm EDT | Khurram JamilChief Medical Officer | 16,250 | $5.13 | $83,285 | 0 | −100% | 10b5-1 |
| Jul 14, 2026 MForm 4 → | Jul 16, 5:39 pm EDT | Khurram JamilChief Medical Officer | 16,250 | $3.04 | $49,400 | 16,250 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 MForm 4 → | Aug 4, 7:52 am EDT | Richard E UihleinDirector, 10% Owner | — | — | — | 0 | — | |
| Jul 14, 2026 MForm 4 → | Jul 16, 5:39 pm EDT | Khurram JamilChief Medical Officer | 16,250 | — | — | 48,750 | — | 10b5-1 |